pre-miRNA Information
pre-miRNA hsa-mir-1268b   
Genomic Coordinates chr17: 80098828 - 80098877
Description Homo sapiens miR-1268b stem-loop
Comment None
RNA Secondary Structure

Mature miRNA Information
Mature miRNA hsa-miR-1268b
Sequence 4| CGGGCGUGGUGGUGGGGGUG |23
Evidence Experimental
Experiments Illumina
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs565586973 1 dbSNP
rs1007008765 2 dbSNP
rs1405843504 4 dbSNP
rs535896040 5 dbSNP
rs532706583 6 dbSNP
rs1290047771 7 dbSNP
rs1228621577 10 dbSNP
rs1377910066 10 dbSNP
rs1282084939 12 dbSNP
rs1449528405 13 dbSNP
rs148335705 13 dbSNP
rs893367645 16 dbSNP
rs1222208792 18 dbSNP
rs1456165025 19 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol KIAA1551   
Synonyms C12orf35, GET, UTA2-1
Description KIAA1551
Transcript NM_018169   
Expression
Putative miRNA Targets on KIAA1551
3'UTR of KIAA1551
(miRNA target sites are highlighted)
>KIAA1551|NM_018169|3'UTR
   1 TTACAAGATGTGGTTTTGTAATTGCCACTGGGAAATTTCTTTCCTTTTCTGTTCAAAATATTTCGCTGAAACTAATGAGA
  81 AATGCCATGATAAAGATTTCTCAGAGTTTGGTTCCCACTTTCATTGTATTTCATTGAAAGTGCTTAATTAAAATGGCTTG
 161 AGAACTTTGGGTAGCCATGTGTAAGAAATGGATGGTATTCACCGGGGAAACAAGGTATTTGAATTTCTACTTTATTGAAC
 241 CAGATTTACCATTATTTTAAAAGGAATGCTTATACAAATCAATTTGAAATTCTACCCATCTTGAGGGAGGACCGTTCCTC
 321 AGTTAAGGACTTGTTTATTTAAATGGGACTGTAAATATGTTTTGGTTTCTAAGCTATATTAGCAAAATTTATTTTTCAAA
 401 AATGCCCACTGTGATGTGAATGTCAAAATATATTCTTAAGTGTTTTATAACTAATTGTAAACTTTTTTTCAGAAGTCTTA
 481 TTTTATACTTGTGAAACTGAACACAATTTTGGGACAACGTTTAAACATTACTTTTCATACTTGAAATAAACATTTATTTT
 561 TTAAAAAACTAAAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' gugggggugguggUGCGGGc 5'
                       |:|||| 
Target 5' ttatttttcaaaaATGCCCa 3'
389 - 408 104.00 -10.30
2
miRNA  3' gugggggugguggUGCGGgc 5'
                       |:|||  
Target 5' aaactaatgagaaATGCCat 3'
69 - 88 84.00 -6.90
3
miRNA  3' gugggggugguGGUGCGGGc 5'
                     |||| ::| 
Target 5' gagtttggttcCCACTTTCa 3'
104 - 123 81.00 -11.92
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN30511422 8 COSMIC
COSN30511420 9 COSMIC
COSN19462192 31 COSMIC
COSN30453398 44 COSMIC
COSN20077742 52 COSMIC
COSN30155073 55 COSMIC
COSN31581171 63 COSMIC
COSN30446987 65 COSMIC
COSN30148604 88 COSMIC
COSN30152275 96 COSMIC
COSN31525488 99 COSMIC
COSN31586002 101 COSMIC
COSN8586000 124 COSMIC
COSN28637255 170 COSMIC
COSN22536184 189 COSMIC
COSN31566841 301 COSMIC
COSN29869481 448 COSMIC
COSN31486611 544 COSMIC
COSN30372258 561 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1244471639 1 dbSNP
rs140283743 2 dbSNP
rs761558428 2 dbSNP
rs769633524 3 dbSNP
rs771759935 4 dbSNP
rs1057085580 5 dbSNP
rs915794016 6 dbSNP
rs369511087 17 dbSNP
rs1388735950 19 dbSNP
rs772819540 21 dbSNP
rs1214383707 33 dbSNP
rs760279522 36 dbSNP
rs1201953055 39 dbSNP
rs771305776 40 dbSNP
rs1262788038 42 dbSNP
rs1184206376 44 dbSNP
rs776800275 47 dbSNP
rs1465553653 49 dbSNP
rs1469897400 52 dbSNP
rs184472712 57 dbSNP
rs11539999 60 dbSNP
rs948440131 61 dbSNP
rs1410938562 62 dbSNP
rs1176610361 65 dbSNP
rs574353842 66 dbSNP
rs1038271779 76 dbSNP
rs552563704 77 dbSNP
rs1464927060 86 dbSNP
rs1249355630 89 dbSNP
rs1207323884 90 dbSNP
rs1464893413 92 dbSNP
rs117220556 93 dbSNP
rs190222249 94 dbSNP
rs146822999 104 dbSNP
rs750910356 113 dbSNP
rs114323263 116 dbSNP
rs562183763 122 dbSNP
rs943946302 123 dbSNP
rs1318690280 125 dbSNP
rs1039603617 136 dbSNP
rs529792454 149 dbSNP
rs1459665882 154 dbSNP
rs549929126 160 dbSNP
rs899746214 169 dbSNP
rs541410860 172 dbSNP
rs998743266 176 dbSNP
rs563258674 178 dbSNP
rs1467349557 185 dbSNP
rs79108287 188 dbSNP
rs1021865622 189 dbSNP
rs1174840475 191 dbSNP
rs1449715882 194 dbSNP
rs1400976670 197 dbSNP
rs375774394 204 dbSNP
rs998987219 205 dbSNP
rs553660884 225 dbSNP
rs1202736670 226 dbSNP
rs1482442556 230 dbSNP
rs139268880 234 dbSNP
rs1206119686 244 dbSNP
rs758923720 245 dbSNP
rs1344668189 247 dbSNP
rs1295458289 255 dbSNP
rs959665687 256 dbSNP
rs991703439 260 dbSNP
rs1022680670 264 dbSNP
rs1228202883 267 dbSNP
rs1311428484 268 dbSNP
rs1313300369 270 dbSNP
rs747326881 274 dbSNP
rs77653313 281 dbSNP
rs973624841 287 dbSNP
rs1312115495 297 dbSNP
rs966794374 300 dbSNP
rs978208496 301 dbSNP
rs1283427136 304 dbSNP
rs1487879924 307 dbSNP
rs769119076 310 dbSNP
rs1190149977 313 dbSNP
rs542069976 314 dbSNP
rs181364628 315 dbSNP
rs993055421 334 dbSNP
rs752285759 345 dbSNP
rs911901155 348 dbSNP
rs1204749541 350 dbSNP
rs1431478138 351 dbSNP
rs943391649 359 dbSNP
rs948620564 360 dbSNP
rs1039048411 375 dbSNP
rs563660359 377 dbSNP
rs899777644 389 dbSNP
rs1338667485 390 dbSNP
rs947274834 398 dbSNP
rs1042913432 410 dbSNP
rs902987734 416 dbSNP
rs1295 419 dbSNP
rs1446457655 421 dbSNP
rs1157147502 431 dbSNP
rs746970857 433 dbSNP
rs1164560859 436 dbSNP
rs1035362259 437 dbSNP
rs895566343 447 dbSNP
rs1417838276 454 dbSNP
rs1012568442 457 dbSNP
rs1181663674 463 dbSNP
rs1250076895 463 dbSNP
rs1473754001 463 dbSNP
rs900918024 466 dbSNP
rs1269557365 474 dbSNP
rs1208185765 479 dbSNP
rs934189358 486 dbSNP
rs1050327668 490 dbSNP
rs1228932359 492 dbSNP
rs1420738503 498 dbSNP
rs1330875791 499 dbSNP
rs1023039036 506 dbSNP
rs1300412835 507 dbSNP
rs890048016 514 dbSNP
rs1324932062 515 dbSNP
rs1384519167 516 dbSNP
rs780321126 517 dbSNP
rs537135102 519 dbSNP
rs902552656 520 dbSNP
rs1410199616 527 dbSNP
rs564923172 528 dbSNP
rs1478464748 529 dbSNP
rs777586179 539 dbSNP
rs1379536927 540 dbSNP
rs1197058812 557 dbSNP
rs1451038233 563 dbSNP
rs1035131023 564 dbSNP
rs1026492865 569 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
     
Conditions HEK293S
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... HITS-CLIP data was present in GSM1084047. RNA binding protein: AGO2. Condition:CLIP_arsenite_rep4 ...

- Karginov FV; Hannon GJ, 2013, Genes & development.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' guGGGGGUGGUGGUGCGGGc 5'
            | |||:||||||||||| 
Target 5' ggCGCCCGCCACCACGCCCa 3'
16 - 35
Article - Karginov FV; Hannon GJ
- Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
CLIP-seq Support 1 for dataset GSM1084047
Method / RBP HITS-CLIP / AGO2
Cell line / Condition HEK293S / CLIP_arsenite_rep4
Location of target site ENST00000312561.4 | 3UTR | GUAGCUGGGAUUACAGGCGCCCGCCACCACGCCCAG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23824327 / GSE44404
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
40 hsa-miR-1268b Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT473716 MAPK1 mitogen-activated protein kinase 1 2 2
MIRT483653 QSOX2 quiescin sulfhydryl oxidase 2 2 4
MIRT484276 AIP aryl hydrocarbon receptor interacting protein 2 4
MIRT486673 WDR81 WD repeat domain 81 2 2
MIRT488670 WWP2 WW domain containing E3 ubiquitin protein ligase 2 2 4
MIRT493452 ITFG3 family with sequence similarity 234 member A 2 2
MIRT495901 ZNF641 zinc finger protein 641 2 2
MIRT500187 BARX1 BARX homeobox 1 2 4
MIRT512014 DNAJC10 DnaJ heat shock protein family (Hsp40) member C10 2 2
MIRT521132 SGPL1 sphingosine-1-phosphate lyase 1 2 4
MIRT530046 TRIM72 tripartite motif containing 72 2 2
MIRT531518 NOM1 nucleolar protein with MIF4G domain 1 2 2
MIRT543735 DHCR7 7-dehydrocholesterol reductase 2 2
MIRT558053 EVI5L ecotropic viral integration site 5 like 2 2
MIRT569602 TRIM29 tripartite motif containing 29 2 2
MIRT570025 FAM228A family with sequence similarity 228 member A 2 2
MIRT573593 CERS1 ceramide synthase 1 2 2
MIRT623883 FRMPD4 FERM and PDZ domain containing 4 2 2
MIRT629999 PDE6B phosphodiesterase 6B 2 2
MIRT632715 MSANTD4 Myb/SANT DNA binding domain containing 4 with coiled-coils 2 2
MIRT633496 ERO1L endoplasmic reticulum oxidoreductase 1 alpha 1 1
MIRT637075 SELPLG selectin P ligand 2 2
MIRT638182 TLN1 talin 1 2 2
MIRT638766 EPB41 erythrocyte membrane protein band 4.1 2 2
MIRT668072 GMPS guanine monophosphate synthase 2 2
MIRT669873 RAET1E retinoic acid early transcript 1E 2 2
MIRT670663 KIAA1551 KIAA1551 2 2
MIRT671282 RPL37A ribosomal protein L37a 2 2
MIRT675054 OR7D2 olfactory receptor family 7 subfamily D member 2 2 2
MIRT682783 BLOC1S3 biogenesis of lysosomal organelles complex 1 subunit 3 2 2
MIRT683343 SCARF1 scavenger receptor class F member 1 2 2
MIRT690282 ZNF154 zinc finger protein 154 2 2
MIRT695171 SLC25A33 solute carrier family 25 member 33 2 2
MIRT695221 SCAMP3 secretory carrier membrane protein 3 2 2
MIRT700484 PTPRF protein tyrosine phosphatase, receptor type F 2 2
MIRT700600 PRKCA protein kinase C alpha 2 2
MIRT701409 NKRF NFKB repressing factor 2 2
MIRT703994 EIF5A2 eukaryotic translation initiation factor 5A2 2 2
MIRT711231 RETSAT retinol saturase 2 2
MIRT719509 TMEM175 transmembrane protein 175 2 2
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-miR-1268b Platinum 23939 sensitive High Ovarian Cancer tissue
hsa-miR-1268b Cisplatin 5460033 NSC119875 approved resistant High Pancreatic Cancer cell line (BxPC-3)
hsa-miR-1268b Doxorubicin 31703 NSC123127 approved sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-1268b Cytoxan + Pirarubicin + Fluorouracil sensitive High Breast Cancer tissue
hsa-miR-1268b Cytoxan + Doxorubicin + Fluorouracil sensitive High Breast Cancer tissue
hsa-miR-1268b Cytoxan + Epirubicin + Fluorouracil sensitive High Breast Cancer tissue
hsa-miR-1268b Doxorubicin + Taxol sensitive High Breast Cancer tissue
hsa-miR-1268b Erlotinib 176870 NSC718781 approved resistant High Head And Neck Squamous Cell Carcinoma cell line (HN6)
hsa-miR-1268b Cisplatin 5460033 NSC119875 approved resistant High Hypopharyngeal Cancer cell line (FaDu)
hsa-miR-1268b Anthracycline 30323 NSC82151 approved sensitive High Breast Cancer tissue
hsa-miR-1268b Cyclophosphamide 2907 NSC26271 approved sensitive High Breast Cancer tissue
hsa-miR-1268b Fluorouracil 3385 NSC19893 approved sensitive High Breast Cancer tissue
hsa-miR-1268b Taxol 36314 NSC125973 approved sensitive High Breast Cancer tissue
hsa-miR-1268b Methotrexate 126941 NSC740 approved sensitive High Breast Cancer tissue
hsa-miR-1268b Doxorubicin 31703 NSC123127 approved sensitive High Colorectal Cancer cell line (HCT8)
hsa-miR-1268b Paclitaxel 36314 NSC125973 approved sensitive High Colorectal Cancer cell line (HCT8)
hsa-miR-1268b Etoposide 36462 NSC141540 approved sensitive High Colorectal Cancer cell line (HCT8)
hsa-miR-1268b Vinorelbine 44424639 approved sensitive High Colorectal Cancer cell line (HCT8)
hsa-miR-1268b Vincristine 5978 approved sensitive High Colorectal Cancer cell line (HCT8)
hsa-mir-1268b Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-1268b Cisplatin 5460033 NSC119875 approved resistant cell line (BxPC3)
hsa-mir-1268b Decitabine 451668 approved sensitive tissue (esopheageal cancer)
hsa-miR-1268b Cisplatin 5460033 NSC119875 approved resistant cell line (A549)
hsa-miR-1268b Cisplatin 5460033 NSC119875 approved sensitive cell line (MGC-803)
hsa-miR-1268b Neoadjuvant chemotherapy sensitive tissue (breast cancer)
hsa-miR-1268b Cisplatin 5460033 NSC119875 approved resistant cell line (MDAH-2774)
hsa-miR-1268b Cisplatin 5460033 NSC119875 approved resistant cell line (OVSAHO)

Error report submission